RAMBALDI ALESSANDRO

Levis, M., Hamadani, M., Logan, B., Jones, R., Singh, A., Litzow, M., et al. (2024). Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3. JOURNAL OF CLINICAL ONCOLOGY [10.1200/jco.23.02474]. Dettaglio

Buracchi, C., Belotti, D., Moretti, A., Calabretta, L., Risca, G., Capelli, C., et al. (2023). Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry. Intervento presentato a: ESLHO Symposium, Salamanca, Spain. Dettaglio

Maggioni, G., Bersanelli, M., Travaglino, E., Alfonso Piérola, A., Kasprzak, A., Sangerman Montserrat, A., et al. (2023). A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study. THE LANCET. HAEMATOLOGY, 10(2 (February 2023)), 117-128 [10.1016/S2352-3026(22)00323-4]. Dettaglio

Biggi, A., Chauvie, S., Fallanca, F., Guerra, L., Bergesio, F., Menga, M., et al. (2023). Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial. HEMATOLOGICAL ONCOLOGY, 41(3 (August 2023)), 415-423 [10.1002/hon.3117]. Dettaglio

Venditti, A., Piciocchi, A., Soddu, S., Frigeni, M., Palmieri, R., Borlenghi, E., et al. (2023). Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial. In 65th ASH Annual Meeting and Exposition - December 9-12, 2023 (pp.1514-1514). AMER SOC HEMATOLOGY [10.1182/blood-2023-178505]. Dettaglio